F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, A. Woronoff et al., Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980.

A. Monnereau, L. Remontet, M. Maynadié, F. Binder-foucard, A. Belot et al., Estimation nationale de l'incidence des cancers en France entre, 1980.

M. Sant, P. Minicozzi, M. Mounier, and L. Anderson, Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study, The Lancet Oncology, vol.15, issue.9, pp.931-973, 2014.
DOI : 10.1016/S1470-2045(14)70282-7

M. Mounier, N. Bossard, L. Remontet, and A. Belot, Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5), The Lancet Haematology, vol.2, issue.11, pp.481-91, 2015.
DOI : 10.1016/S2352-3026(15)00155-6

F. Berrino, D. Angelis, R. Sant, and M. , Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995???99: results of the EUROCARE-4 study, The Lancet Oncology, vol.8, issue.9, pp.773-83, 2007.
DOI : 10.1016/S1470-2045(07)70245-0

URL : https://hal.archives-ouvertes.fr/hal-00492650

H. Howe, A Review of the Definition for Multiple Primary Cancers in the United States, Princeton, New Jersey. Springfield (IL): North American Association of Central Cancer Registries, 2002.

C. Moertel, M. Dockerty, and A. Baggenstoss, Multiple primary malignant neoplasms.I. Introduction and presentation of data, Cancer, vol.6, issue.2, pp.221-251, 1961.
DOI : 10.1002/1097-0142(196103/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6

C. Moertel, M. Dockerty, and A. Baggenstoss, Multiple primary malignant neoplasms.II. Tumors of different tissues or organs, Cancer, vol.146, issue.2, pp.231-238, 1961.
DOI : 10.1002/1097-0142(196103/04)14:2<231::AID-CNCR2820140203>3.0.CO;2-2

C. Moertel, INCIDENCE AND SIGNIFICANCE OF MULTIPLE PRIMARY MALIGNANT NEOPLASMS*, Annals of the New York Academy of Sciences, vol.209, issue.2, pp.886-95, 1964.
DOI : 10.1111/j.1749-6632.1964.tb41011.x

C. Demandante, D. Troyer, and T. Miles, Multiple Primary Malignant Neoplasms, American Journal of Clinical Oncology, vol.26, issue.1, pp.79-83, 2003.
DOI : 10.1097/00000421-200302000-00015

S. Sacchi, . Marcheselli, A. Bari, and R. Marcheselli, Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study, Haematologica, vol.93, issue.3, pp.398-404, 2008.
DOI : 10.3324/haematol.12120

J. D. Tward, W. M. , S. D. Szabo, and A. , The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma, Cancer, vol.89, issue.1, pp.108-115, 2006.
DOI : 10.1002/cncr.21971

K. Hemminki, P. Lenner, J. Sundquist, and B. J. , Risk of Subsequent Solid Tumors After Non-Hodgkin's Lymphoma: Effect of Diagnostic Age and Time Since Diagnosis, Journal of Clinical Oncology, vol.26, issue.11, pp.1850-1857, 2008.
DOI : 10.1200/JCO.2007.14.6068

P. Brennan, G. Scelo, K. Hemminki, and L. Mellemkjaer, Second primary cancers among 109???000 cases of non-Hodgkin's lymphoma, British Journal of Cancer, vol.69, issue.1, pp.159-166, 2005.
DOI : 10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R

C. Rossi, J. Jégu, M. Mounier, and M. Dandoit, Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma, Leukemia & Lymphoma, vol.18, issue.82, pp.1-7, 2015.
DOI : 10.1054/bjoc.2001.1998

L. Travis, R. Curtis, and B. Glimelius, Second Cancers Among Long-term Survivors of Non-Hodgkin's Lymphoma, JNCI Journal of the National Cancer Institute, vol.85, issue.23, pp.1932-1937, 1993.
DOI : 10.1093/jnci/85.23.1932

E. Arpaci, S. Tokluoglu, T. Yetigyigit, and N. Alkis, Multiple Primary Malignancies - A Retrospective Analysis at a Single Center in Turkey, Asian Pacific Journal of Cancer Prevention, vol.14, issue.2, pp.769-773, 2013.
DOI : 10.7314/APJCP.2013.14.2.769

I. Mehdi, A. H. Shah, M. M. Verma, and K. , Synchronous and metachronous malignant tumors expect the un-expected, J Pak Med Assoc, pp.905-909, 2010.

N. Hulikal, S. Ray, J. Thomas, and D. J. Fernandes, Second Primary Malignant Neoplasms: A Clinicopathological Analysis from a Cancer Centre in India, Asian Pacific Journal of Cancer Prevention, vol.13, issue.12, pp.6087-6091, 2012.
DOI : 10.7314/APJCP.2012.13.12.6087

M. Hayat, N. Howlader, M. Reichman, and B. Edwards, Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program, The Oncologist, vol.12, issue.1, pp.20-37, 2007.
DOI : 10.1634/theoncologist.12-1-20

A. Gallamini, C. Zwarthoed, and A. Borra, Positron Emission Tomography (PET) in Oncology, Cancers, vol.6, issue.4, pp.1821-89, 2014.
DOI : 10.3390/cancers6041821

S. Barrington, N. Mikhaeel, L. Kostakoglu, and . Meignan, Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group, Journal of Clinical Oncology, vol.32, issue.27, pp.3048-58, 2014.
DOI : 10.1200/JCO.2013.53.5229

A. Fritz, C. Percy, and A. Lang, International classification of diseases for oncology, Geneva: World Health, 2008.

A. Gavin, B. Rous, R. Marcos-gragera, and R. Middleton, Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses, European Journal of Cancer, vol.51, issue.9, pp.1109-1131, 2015.
DOI : 10.1016/j.ejca.2014.02.008

N. Yamaguchi, Epidemiologic Approaches to Multiple Primary Cancer: Critical Review from the Standpoints of Validity and Efficiency. Jpn, J Clin Oncol, vol.20, pp.1-6, 1990.

N. Breslow and N. Day, Statistical methods in cancer research. The design and analysis of cohort studies, IARC Sci Publ, issue.82, pp.1-406, 1987.

T. Tihan and F. D. , Coexistence of renal cell carcinoma and malignant lymphoma: A causal relationship or coincidental occurrence?, Cancer, vol.14, issue.11, pp.2325-2339, 1996.
DOI : 10.1002/(SICI)1097-0142(19960601)77:11<2325::AID-CNCR22>3.0.CO;2-Y

C. Anderson, L. Puszatai, L. Palmer, and F. Cabanillas, COINCIDENT RENAL CELL CARCINOMA AND NONHODGKIN'S LYMPHOMA: THE M.D. ANDERSON EXPERIENCE AND REVIEW OF THE LITERATURE, The Journal of Urology, vol.159, issue.3, pp.714-716, 1998.
DOI : 10.1016/S0022-5347(01)63708-X

C. Nishikubo, L. Kunkel, R. Figlin, A. Belldegrun, and H. Wang, An association between renal cell carcinoma and lymphoid malignancies: A case series of eight patients, Cancer, vol.11, issue.11, pp.2421-2427, 1996.
DOI : 10.1002/(SICI)1097-0142(19961201)78:11<2421::AID-CNCR21>3.0.CO;2-1

A. Kunthur, P. Wiernik, and J. Dutcher, Renal parenchymal tumors and lymphoma in the same patient: Case series and review of the literature, American Journal of Hematology, vol.35, issue.4, pp.271-80, 2006.
DOI : 10.1002/ajh.20533

I. Barista, F. Cabanillas, R. J. , and K. I. , Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?, Annals of Oncology, vol.13, issue.2, pp.318-322, 2002.
DOI : 10.1093/annonc/mdf042

J. Jégu, M. Colonna, and L. Daubisse-marliac, The effect of patient characteristics on second primary risk cancer un France, BMC Cancer, pp.14-94, 2014.

A. Joly-battaglini, C. Hammarstrom, and B. Stankovic, Rituximab efficiently depletes B cells in lung tumors??and normal lung tissue, F1000Research, vol.5, p.38, 2016.
DOI : 10.12688/f1000research.7599.1

C. Ho and S. Rodig, Immunohistochemical markers in lymphoid malignancies: Protein correlates of molecular alterations, Seminars in Diagnostic Pathology, vol.32, issue.5, pp.381-391, 2015.
DOI : 10.1053/j.semdp.2015.02.016

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

A. Michalinos, T. Vassilakopoulos, and G. Levidou, Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence?, Journal of Breast Cancer, vol.18, issue.3, pp.296-300, 2015.
DOI : 10.4048/jbc.2015.18.3.296

URL : http://doi.org/10.4048/jbc.2015.18.3.296

W. Liu, H. Zhu, and X. Zhou, Synchronous bilateral non-Hodgkin's diffuse large B cell lymphoma of the breast and left breast invasive ductal carcinoma: a case report and review of literature, Int J Clin Exp Pathol, vol.7, pp.7042-7048, 2014.

F. A. Siddiqui, V. Maheshwari, and K. Alam, Coexistent non-hodgkin's lymphoma and ductal carcinoma breast: diagnosis one fine needle aspiration cytology, Diagnostic cytopathology, pp.767-769, 2010.
DOI : 10.1002/dc.21547

T. Stewart, R. Sage, and D. Cameron, Breast cancer incidence highest in range of one spieces of mouse, Brit J. Cancer, vol.82, pp.446-451, 2000.

Y. Li, B. Welm, K. Podsypania, and S. Huang, Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells, Proceedings of the National Academy of Sciences, vol.100, issue.26, pp.15853-15858, 2003.
DOI : 10.1073/pnas.2136825100

R. Guo, L. Chang, Z. Liu, A. Li, Q. Huang et al., Canonical Nuclear Factor ??B Pathway Links Tumorigenesis of Synchronous Mantle-Cell Lymphoma, Clear-Cell Renal-Cell Carcinoma, and GI Stromal Tumor, Journal of Clinical Oncology, vol.29, issue.10, pp.257-61, 2011.
DOI : 10.1200/JCO.2010.32.1802

M. Karin, NF-kB as a critical link between inflammation and cancer, Cold Spring Harb Perspect Biol, pp.11-14, 2009.
DOI : 10.1101/cshperspect.a000141

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773649

C. Fremd, F. Schuetz, and C. Sohn, B cell-regulated immune responses in tumor models and cancer patients, OncoImmunology, vol.11, issue.7, pp.7-25443, 2013.
DOI : 10.1002/cncr.26204

M. Linnebacher and C. Maletzki, Tumor-infiltrating B cells, OncoImmunology, vol.1, issue.7, pp.1186-1188
DOI : 10.1016/j.coi.2008.03.003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494640

L. Martinet, I. Garrido, and T. Filleron, Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer, Cancer Research, vol.71, issue.17, pp.5678-5687, 2011.
DOI : 10.1158/0008-5472.CAN-11-0431

M. Campa, M. Moody, and R. Zhang, Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery, Cancer Immunology, Immunotherapy, vol.9, issue.2, pp.171-180, 2016.
DOI : 10.1007/s00262-015-1787-0

M. Dieu-nosjean, N. Giraldo, and H. Kaplon, Tertiary lymphoid strutures, drivers of the anti-tumor responses in human cancers, Immunological Reviews, pp.260-275, 2016.

E. Pimenta and B. Barnes, Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers, Cancers, vol.6, issue.2, pp.969-997, 2014.
DOI : 10.3390/cancers6020969

C. Maletzki, A. Jahnke, and C. Ostwald, Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of immature immunophenotype and produce functional IgG, Plos One, vol.7, 2012.

K. Silina, U. Rulle, and Z. Kalnina, Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?, Cancer Immunology, Immunotherapy, vol.1, issue.1, pp.643-662, 2014.
DOI : 10.1007/s00262-014-1544-9